INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $10,000 | +25.0% | 2,200 | 0.0% | 0.00% | – |
Q4 2018 | $8,000 | -63.6% | 2,200 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $22,000 | +37.5% | 2,200 | 0.0% | 0.00% | – |
Q2 2018 | $16,000 | +23.1% | 2,200 | 0.0% | 0.00% | – |
Q1 2018 | $13,000 | -38.1% | 2,200 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $21,000 | +5.0% | 2,200 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $20,000 | -28.6% | 2,200 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $28,000 | +21.7% | 2,200 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $23,000 | +15.0% | 2,200 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $20,000 | -4.8% | 2,200 | +193.3% | 0.00% | 0.0% |
Q4 2015 | $21,000 | – | 750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 697,763 | $27,010,000 | 4.43% |
Tamarack Capital Management, LLC | 235,000 | $9,097,000 | 2.15% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 196,117 | $7,591,000 | 0.64% |
EMERALD MUTUAL FUND ADVISERS TRUST | 132,862 | $6,093,000 | 0.36% |
EMERALD ADVISERS, LLC | 118,242 | $4,577,000 | 0.25% |
PDT Partners, LLC | 30,038 | $1,163,000 | 0.14% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 96,334 | $3,729,000 | 0.14% |
Convergence Investment Partners, LLC | 17,450 | $675,000 | 0.11% |
ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 122,556 | $4,744,000 | 0.11% |
Spark Investment Management LLC | 13,992 | $541,000 | 0.09% |